Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Rising incidence of hepatocellular carcinoma in the United States.

El-Serag HB, Mason AC.

N Engl J Med. 1999 Mar 11;340(10):745-50.

2.

Risk factors for the rising rates of primary liver cancer in the United States.

El-Serag HB, Mason AC.

Arch Intern Med. 2000 Nov 27;160(21):3227-30.

PMID:
11088082
3.

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update.

El-Serag HB, Davila JA, Petersen NJ, McGlynn KA.

Ann Intern Med. 2003 Nov 18;139(10):817-23. Erratum in: Ann Intern Med. 2004 Jan 20;140(2):151.

PMID:
14623619
4.

Geographic variation within the United States in the incidence of hepatocellular carcinoma.

Davila JA, Petersena NJ, Nelson HA, El-Serag HB.

J Clin Epidemiol. 2003 May;56(5):487-93.

PMID:
12812824
5.

National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.

Ahmed F, Perz JF, Kwong S, Jamison PM, Friedman C, Bell BP.

Prev Chronic Dis. 2008 Jul;5(3):A74. Epub 2008 Jun 15.

6.

Epidemiology of primary hepatic malignancies in U.S. children.

Darbari A, Sabin KM, Shapiro CN, Schwarz KB.

Hepatology. 2003 Sep;38(3):560-6.

PMID:
12939582
7.

Epidemiology of hepatocellular carcinoma in Hispanics in the United States.

El-Serag HB, Lau M, Eschbach K, Davila J, Goodwin J.

Arch Intern Med. 2007 Oct 8;167(18):1983-9.

PMID:
17923599
8.

Childhood cancer among Alaska Natives.

Lanier AP, Holck P, Ehrsam Day G, Key C.

Pediatrics. 2003 Nov;112(5):e396.

PMID:
14595083
9.
10.

Hepatocellular carcinoma - United States, 2001-2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 May 7;59(17):517-20.

11.

Mortality from hepatocellular and biliary cancers: changing epidemiological trends.

Nair S, Shiv Kumar K, Thuluvath PJ.

Am J Gastroenterol. 2002 Jan;97(1):167-71. Erratum in: Am J Gastroenterol 2002 May;97(5):1280. Shivakumar KS [corrected to Shiva Kumar K]. Am J Gastroenterol 2002 Aug;97(9):2484. Shiva Kumar K [corrected to Shiv Kumar K].

PMID:
11808943
12.

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Altekruse SF, McGlynn KA, Reichman ME.

J Clin Oncol. 2009 Mar 20;27(9):1485-91. doi: 10.1200/JCO.2008.20.7753. Epub 2009 Feb 17.

13.

Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study.

Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB.

Gastroenterology. 2004 Nov;127(5):1372-80.

PMID:
15521006
14.

Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century.

Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisani F; EUROCARE Working Group.

Am J Gastroenterol. 2007 Aug;102(8):1661-70; quiz 1660, 1671. Epub 2007 Jun 6.

PMID:
17555459
15.
16.
17.

Assessing changes in the impact of cancer on population survival without considering cause of death.

Brown BW, Brauner C, Levy LB.

J Natl Cancer Inst. 1997 Jan 1;89(1):58-65.

18.

Trends in palatine tonsillar cancer incidence and mortality rates in the United States.

Golas SM.

Community Dent Oral Epidemiol. 2007 Apr;35(2):98-108.

PMID:
17331151
19.

Prostate cancer incidence and mortality rates and trends in the United States and Canada.

McDavid K, Lee J, Fulton JP, Tonita J, Thompson TD.

Public Health Rep. 2004 Mar-Apr;119(2):174-86.

20.

Trends in prostate cancer mortality among black men and white men in the United States.

Chu KC, Tarone RE, Freeman HP.

Cancer. 2003 Mar 15;97(6):1507-16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk